HomeG28 • FRA
add
Tevogen Bio Holdings Inc
Previous close
€0.31
Day range
€0.30 - €0.30
Year range
€0.30 - €2.28
Market cap
74.09M USD
Avg Volume
37.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.73M | -5.85% |
Net income | -5.73M | 2.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.73M | 5.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.04M | -55.50% |
Total assets | 4.49M | 4.76% |
Total liabilities | 12.32M | 17.53% |
Total equity | -7.82M | — |
Shares outstanding | 198.69M | — |
Price to book | -3.91 | — |
Return on assets | -326.92% | — |
Return on capital | 1,288.38% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.73M | 2.68% |
Cash from operations | -3.65M | 4.08% |
Cash from investing | — | — |
Cash from financing | 4.00M | -19.97% |
Net change in cash | 351.86K | -70.56% |
Free cash flow | -1.40M | 4.41% |
About
Founded
2020
Headquarters
Website
Employees
18
